Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients
ABSTRACT Background The management of acute myeloid leukemia (AML) is hindered by treatment‐related toxicities and complications, particularly cytopenia, which remains a leading cause of mortality. Given the pivotal role of the gut microbiota (GM) in hemopoiesis and immune regulation, we investigate...
Saved in:
Main Authors: | Valentina Salvestrini, Gabriele Conti, Federica D'Amico, Gianluca Cristiano, Marco Candela, Michele Cavo, Silvia Turroni, Antonio Curti |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-02-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.70501 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myeloid sarcoma: clinical features, bone marrow hematological characteristics, and prognosis of 20 cases
by: LIU Xian, HUANG Lifang, MENG Fankai, MENG Li, WANG Zhiqiong
Published: (2025-02-01) -
Measurable residual disease in hematologic malignancies: a biomarker in search of a standard
by: Namrata S. Chandhok, et al.
Published: (2025-08-01) -
ACUTE MYELOID LEUKEMIA PRESENTING AS ISOLATED MYELOID SARCOMA: A CASE REPORT
by: Elif Canpolat Hırfanoğlu, et al.
Published: (2025-07-01) -
PECULIARITIES OF CHRONIC MYELOID LEUKEMIA INCIDENCE IN THE ALTAi krai
by: O. V. Efremova, et al.
Published: (2019-05-01) -
CHRONIC MYELOID LEUKEMIA - CLINICAL AND IMMUNOLOGICAL PECULIARITIES IN ADULT PATIENTS
by: O. V. Smirnova
Published: (2012-05-01)